Amid growing health crises and increasing global competition in pharmaceuticals, a novel FDA initiative aims to fast-track drug reviews by slashing approval times for essential medicines. Can this new approach significantly impact domestic drug manufacturing, or does it introduce unprecedented
In a decisive leap toward revolutionizing gene therapy, ProBio has unveiled its cutting-edge facility in Hopewell, New Jersey. This facility is poised to become a key player in the production of high-quality plasmid, lentiviral, and adeno-associated viral vectors tailored for genomic medicine. With
As the biopharmaceutical sector traverses the complex terrain of 2025, it encounters a multitude of challenges shaped by financial constraints, regulatory shifts, and evolving geopolitical dynamics. The industry is marked by notable changes detailed in Ernst & Young LLP's (EY) annual Biotech Beyond
Veranova has announced a major expansion of its Devens, Massachusetts facility, marking a significant step forward in the development and manufacturing of Antibody-Drug Conjugates (ADCs) and highly potent compounds. The company is investing $50 million to extend the facility by 9,000 square feet,
The biopharmaceutical industry finds itself at a crossroads as the ever-increasing global demand for pharmaceuticals necessitates a reevaluation of traditional manufacturing approaches. With escalating costs and inefficiencies hindering timely drug production, the sector is turning towards a
In recent scientific developments, researchers from Kiel University and the University of Hamburg have unveiled a pioneering method to direct atomic movement using magnetism. Traditionally, the movement of individual atoms across a surface was assumed random, a belief now challenged by these